Access to innovative oncology medicines in Europe

The incidence of cancer will increase within the next 5 years up to 15 million patients per year worldwide with a further increasing tendency. Therefore, there is a requirement for more emphasis on cancer prevention, research and effective anticancer drugs including a rapid licensing and market avai...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergmann, L., Enzmann, H., Thirstrup, S., Schweim, J. K., Widera, I., Zwierzina, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Industry Corner: Early Drug Development
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722892/
https://www.ncbi.nlm.nih.gov/pubmed/26578739
http://dx.doi.org/10.1093/annonc/mdv547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722892/
https://www.ncbi.nlm.nih.gov/pubmed/26578739
http://dx.doi.org/10.1093/annonc/mdv547

Ejemplares similares